Journal of Crohn s and Colitis 2023

11 papers
In 2023, the Journal of Crohn’s and Colitis emphasized the integration of artificial intelligence and automated analysis in inflammatory bowel disease (IBD) diagnostics. Research focused on deep learning models for assessing histological disease activity and AI-assisted pan-enteric capsule endoscopy. These efforts aimed to improve cross-anatomical generalization in medical imaging and develop high negative predictive value models for clinical rule-out. Additionally, the introduction of the Escalation of Therapy or Intervention (ETI) calculator demonstrated a trend toward utilizing electronic patient-reported outcome measures for clinical monitoring. The year’s publications also highlighted advancements in metagenomics and biomarker discovery. The ENIGMA study provided insights into the colonic mucosa-associated microbiota, identifying specific bacterial consortia and secretomes linked to Crohn’s disease. Other studies explored plasma N-glycan biomarkers to predict treatment response and compared proactive versus reactive dosing strategies for infliximab in pediatric patients. Prolific authors such as Siew C. Ng, Joseph JY Sung, and Amy L. Hamilton contributed to these themes, alongside research evaluating the economic and satisfaction impacts of telehealth services following the pandemic.

Top Research Directions

The 10 research directions with Journal of Crohn s and Colitis 2023 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Attention Based Multiple Instance Learning19.1%
2Dynamically Weighting Hard Examples to Mitigate Class Imbalance19.1%
3Expert-Level Medical Diagnosis with Deep Learning19.1%
4Mitigating Class Imbalance in Clinical Machine Learning19.1%
5Multiple Instance Learning for Weakly Supervised Image Classification19.1%
6Negative Predictive Value Optimization for Clinical Triage19.1%
7Overcoming Anatomical Domain Shift in Medical Imaging19.1%
8Overcoming Diagnostic Subjectivity with Computational Pathology19.1%
9Overcoming Single Annotator Bias in Machine Learning19.1%
10Robust Model Evaluation via K-Fold Cross-Validation19.1%

Download all directions as CSV

Institutions

Institutions credited by Journal of Crohn s and Colitis 2023 papers: a paper credits every institution named in its affiliations, once. 10 institutions share 2 credited papers.

#InstitutionPapersShare
100ey0ed83 150.0%
201875pg84 150.0%
304jewc589 150.0%
405wae1a98 150.0%
5Centre National de la Recherche Scientifique 150.0%
6Equipes Traitement de l'Information et Systèmes 150.0%
7Jagiellonian University 150.0%
8KU Leuven 150.0%
9Sorbonne Université 150.0%
10University of Southern Denmark 150.0%

Download all institutions as CSV

About this data

Papers. Journal of Crohn s and Colitis 2023 lists 11 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 11 papers (18.2%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Crohn s and Colitis 2023”, https://lacuna.tiptreesystems.com/venue/journal-of-crohn-s-and-colitis/2023.

Top Authors

AuthorPapers
Joseph JY Sung2
Bartosz Michał Zieliński1
Dawid Damian Rymarczyk1
Joon-Hyuk Ko1
Tomasz Danel1

Impactful Papers

Papers from Journal of Crohn s and Colitis 2023 that shaped research clusters.

Influential

Papers

Title
Artificial Intelligence-assisted Analysis of Pan-enteric Capsule Endoscopy in Patients with Suspected Crohn’s Disease: A Study on Diagnostic Performance
Deep Learning Models Capture Histological Disease Activity in Crohn’s Disease and Ulcerative Colitis with High Fidelity
Development of the Escalation of Therapy or Intervention (ETI) Calculator for Patients with Ulcerative Colitis Using ePROMs
DOP35 High-fat diet reduces gut microbiota-derived metabolite indole-acetic acid and aggravates colitis
DOP48 Key Anti-Inflammatory Faecalibacterium prausnitzii is Heterogeneous and Diverse in the East and West and in Health and Crohn’s disease. The ENIGMA study.
DOP49 Metagenomic Characterisation of The Colonic Mucosa-Associated Microbiota Reveals Novel Microbes and Communities in Health and Crohn’s disease. The ENIGMA study.
DOP83 Proactive dosing is superior to clinically based dosing in terms of endoscopic healing in paediatric patients with Crohn’s disease receiving maintenance infliximab: A randomized controlled trial
OP03 Highly stable epigenome-wide peripheral blood DNA methylation signatures accurately predict endoscopic response to adalimumab, vedolizumab and ustekinumab in Crohn’s disease patients: The EPIC-CD
P432 Patient satisfaction and patient costs associated with telephone clinic appointments in Inflammatory Bowel Disease (IBD) following the pandemic
P803 Plasma N-glycan biomarkers predict patient Response to Vedolizumab treatment for Crohn’s Disease
P925 Deep functional assessment of the colonic mucosa-associated microbiota in Crohn’s disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIG